LifeStance appoints David Bourdon as CFO, J. Michael Bruff to Business Transformation Officer

LifeStance Health Group, Inc.

David Bourdon appointed CFO effective Nov 10, 2022; succeeds J. Michael Bruff who becomes Business Transformation Officer.
Bourdon's annual base salary $500k, target bonus 75% of base, $1M stock signing bonus subject to repayment before 4-year anniversary.
Bourdon granted option to purchase 1.25M shares of LFST common stock; 1/3 time-based vesting over 4 years, 2/3 performance-based.
Bruff transition: retains $1.5M sign-on bonus, surrenders ~$1M in shares, accelerated vesting of RSUs and RSAs on effective date.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

J. Michael Bruff

leader of its Business Transformation office

LFST · LifeStance Health Group, Inc.

Effective: 2022-11-10
Successor: David Bourdon
Filed: November 3, 2022, 7:59 PM ET

Mr. Bruff will continue to be employed by the Company as the leader of its Business Transformation office.

Appointed

David Bourdon

Chief Financial Officer and Treasurer

LFST · LifeStance Health Group, Inc.

Effective: 2022-11-10
Filed: November 3, 2022, 7:59 PM ET

On November 2, 2022, the Board of Directors of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) appointed David Bourdon as the Company’s new Chief Financial Officer and Treasurer effective as of November 10, 2022 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

J. Michael Bruff changed role as leader of its Business Transformation office at LifeStance Health Group, Inc..

Action: transitioned
Role: leader of its Business Transformation office

Exact text from the filing

Mr. Bruff will continue to be employed by the Company as the leader of its Business Transformation office.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David Bourdon was appointed as Chief Financial Officer and Treasurer at LifeStance Health Group, Inc..

Action: appointed
Role: Chief Financial Officer and Treasurer

Exact text from the filing

On November 2, 2022, the Board of Directors of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) appointed David Bourdon as the Company’s new Chief Financial Officer and Treasurer effective as of November 10, 2022 (the “Effective Date”).

View on SEC.gov

LifeStance Health Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-276872

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.